Why is P & G Health Ltd falling/rising?

As of 16-Sep, Procter & Gamble Health Ltd's stock price is currently at 6,337.50, reflecting an increase of 66.4 points or 1.06%. The stock has been gaining for the last two days, with a total return of 1.48% during this period. It outperformed its sector by 0.78% today and reached an intraday high of Rs 6397.35, marking a 2.01% increase. Over the past year, the stock has generated a return of 22.94%, significantly outperforming the BSE500 index, which has seen a decline of 0.73%. However, despite these positive indicators, there are concerns regarding long-term growth, as net sales have only grown at an annual rate of 7.39% over the last five years.
In the broader market context, the stock's short-term performance has been less favorable compared to the benchmark, as it has declined by 2.12% over the past week while the Sensex has increased by 1.58%. Despite this, the stock's long-term performance remains strong, with a 21.17% year-to-date return compared to the Sensex's 5.43%. The company's high management efficiency, low debt-to-equity ratio, and consistent positive quarterly results contribute to its appeal among institutional investors, who hold 21.15% of the stock. However, the stock's high valuation, indicated by a Price to Book Value of 19.6, raises concerns about its sustainability in the long run.